Mutual of America Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $13M | Sell |
26,109
-858
| -3% | -$380K | 0.13% | 143 |
|
|
2026
Q1 | $12M | Sell |
26,967
-230
| -0.8% | -$107K | 0.14% | 133 |
|
|
2025
Q4 | $12.3M | Sell |
27,197
-549
| -2% | -$237K | 0.13% | 134 |
|
|
2025
Q3 | $10.9M | Sell |
27,746
-1,660
| -6% | -$694K | 0.11% | 170 |
|
|
2025
Q2 | $13.1M | Sell |
29,406
-2,069
| -7% | -$953K | 0.14% | 121 |
|
|
2025
Q1 | $15.3M | Sell |
31,475
-1,424
| -4% | -$664K | 0.18% | 95 |
|
|
2024
Q4 | $13.2M | Sell |
32,899
-933
| -3% | -$432K | 0.14% | 113 |
|
|
2024
Q3 | $15.7M | Sell |
33,832
-763
| -2% | -$367K | 0.17% | 89 |
|
|
2024
Q2 | $16.2M | Buy |
34,595
+844
| +3% | +$366K | 0.18% | 84 |
|
|
2024
Q1 | $14.1M | Sell |
33,751
-688
| -2% | -$291K | 0.15% | 106 |
|
|
2023
Q4 | $14M | Sell |
34,439
-1,635
| -5% | -$604K | 0.16% | 99 |
|
|
2023
Q3 | $12.5M | Sell |
36,074
-929
| -3% | -$325K | 0.15% | 106 |
|
|
2023
Q2 | $13M | Buy |
37,003
+254
| +0.7% | +$85.6K | 0.15% | 109 |
|
|
2023
Q1 | $11.6M | Buy |
36,749
+118
| +0.3% | +$35.4K | 0.14% | 123 |
|
|
2022
Q4 | $10.6M | Buy |
36,631
+1,158
| +3% | +$353K | 0.13% | 141 |
|
|
2022
Q3 | $10.3M | Buy |
35,473
+633
| +2% | +$182K | 0.14% | 128 |
|
|
2022
Q2 | $9.82M | Buy |
34,840
+894
| +3% | +$239K | 0.13% | 145 |
|
|
2022
Q1 | $8.86M | Buy |
33,946
+396
| +1% | +$94K | 0.09% | 246 |
|
|
2021
Q4 | $7.37M | Sell |
33,550
-464
| -1% | -$90.2K | 0.07% | 351 |
|
|
2021
Q3 | $6.17M | Buy |
34,014
+261
| +0.8% | +$51K | 0.06% | 406 |
|
|
2021
Q2 | $6.81M | Sell |
33,753
-2,711
| -7% | -$567K | 0.07% | 371 |
|
|
2021
Q1 | $7.84M | Buy |
36,464
+440
| +1% | +$96.6K | 0.08% | 297 |
|
|
2020
Q4 | $8.51M | Buy |
36,024
+1,958
| +6% | +$449K | 0.1% | 227 |
|
|
2020
Q3 | $9.27M | Sell |
34,066
-965
| -3% | -$266K | 0.12% | 150 |
|
|
2020
Q2 | $10.2M | Sell |
35,031
-32
| -0.1% | -$8.68K | 0.14% | 116 |
|
|
2020
Q1 | $8.34M | Buy |
35,063
+409
| +1% | +$93.8K | 0.14% | 127 |
|
|
2019
Q4 | $7.59M | Buy |
34,654
+146
| +0.4% | +$29.5K | 0.1% | 245 |
|
|
2019
Q3 | $5.85M | Buy |
34,508
+343
| +1% | +$60.7K | 0.08% | 322 |
|
|
2019
Q2 | $6.26M | Buy |
34,165
+38
| +0.1% | +$6.64K | 0.09% | 280 |
|
|
2019
Q1 | $6.28M | Buy |
34,127
+208
| +0.6% | +$38.4K | 0.09% | 272 |
|
|
2018
Q4 | $5.62M | Buy |
33,919
+927
| +3% | +$161K | 0.09% | 277 |
|
|
2018
Q3 | $6.36M | Buy |
32,992
+160
| +0.5% | +$28.5K | 0.09% | 287 |
|
|
2018
Q2 | $5.58M | Buy |
32,832
+348
| +1% | +$53.9K | 0.08% | 325 |
|
|
2018
Q1 | $5.29M | Buy |
32,484
+464
| +1% | +$75.8K | 0.08% | 342 |
|
|
2017
Q4 | $4.8M | Buy |
32,020
+1,865
| +6% | +$276K | 0.07% | 396 |
|
|
2017
Q3 | $4.58M | Sell |
30,155
-6,048
| -17% | -$910K | 0.08% | 397 |
|
|
2017
Q2 | $4.67M | Buy |
36,203
+6,684
| +23% | +$805K | 0.08% | 371 |
|
|
2017
Q1 | $3.23M | Sell |
29,519
-453
| -2% | -$39.9K | 0.06% | 559 |
|
|
2016
Q4 | $2.21M | Buy |
29,972
+1,902
| +7% | +$155K | 0.04% | 733 |
|
|
2016
Q3 | $2.45M | Sell |
28,070
-730
| -3% | -$69K | 0.05% | 633 |
|
|
2016
Q2 | $2.48M | Sell |
28,800
-3,962
| -12% | -$342K | 0.05% | 593 |
|
|
2016
Q1 | $2.6M | Sell |
32,762
-103
| -0.3% | -$9.32K | 0.06% | 530 |
|
|
2015
Q4 | $4.13M | Buy |
32,865
+173
| +0.5% | +$20.9K | 0.09% | 283 |
|
|
2015
Q3 | $3.4M | Buy |
32,692
+357
| +1% | +$45.9K | 0.08% | 364 |
|
|
2015
Q2 | $3.99M | Sell |
32,335
-909
| -3% | -$115K | 0.09% | 323 |
|
|
2015
Q1 | $3.92M | Buy |
33,244
+1,311
| +4% | +$157K | 0.09% | 332 |
|
|
2014
Q4 | $3.79M | Buy |
31,933
+966
| +3% | +$109K | 0.09% | 343 |
|
|
2014
Q3 | $3.48M | Sell |
30,967
-75
| -0.2% | -$7.14K | 0.08% | 344 |
|
|
2014
Q2 | $2.94M | Sell |
31,042
-2,247
| -7% | -$158K | 0.07% | 467 |
|
|
2014
Q1 | $2.35M | Buy |
33,289
+9,267
| +39% | +$734K | 0.06% | 599 |
|
|
2013
Q4 | $1.78M | Sell |
24,022
-1,806
| -7% | -$126K | 0.04% | 719 |
|
|
2013
Q3 | $1.96M | Sell |
25,828
-106,393
| -80% | -$8.47M | 0.05% | 621 |
|
|
2013
Q2 | $10.6M | Buy |
+132,221
| New | +$9.74M | 0.31% | 38 |
|
Other funds holding VRTX
Mutual of America Capital Management's VRTX Position: Q2 2026 in Review
Mutual of America Capital Management reduced its Vertex Pharmaceuticals (VRTX) stake by 3.2% in Q2 2026, selling an estimated $380K and leaving 26,109 shares worth $13M. The position accounts for 0.13% of the portfolio, ranked #143.
Mutual of America Capital Management first reported a position in VRTX in Q2 2013 and has held it in 53 quarters since. The position peaked at $16.2M in Q2 2024. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Mutual of America Capital Management held 26,109 shares of Vertex Pharmaceuticals worth $13M as of Q2 2026.
- Mutual of America Capital Management sold 858 Vertex Pharmaceuticals shares in Q2 2026, an estimated $380K.
- Vertex Pharmaceuticals made up 0.13% of Mutual of America Capital Management's portfolio in Q2 2026, its #143 holding.
- Mutual of America Capital Management first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Mutual of America Capital Management's Vertex Pharmaceuticals position peaked at $16.2M in Q2 2024.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Mutual of America Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.